Publication
Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems
dc.contributor.author | Olim, Filipe | |
dc.contributor.author | Neves, Ana Rute | |
dc.contributor.author | Wang, Zhao | |
dc.contributor.author | Sun, Jingjing | |
dc.contributor.author | Tomás, Helena | |
dc.contributor.author | Sheng, Ruilong | |
dc.date.accessioned | 2021-11-16T14:22:44Z | |
dc.date.available | 2021-11-16T14:22:44Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Using natural lipids to covalently connect with antitumor agents to construct lipid-based molecular prodrugs and their nanosystems is a promising research frontier for sustainable medicinal chemistry, nanobiotechnology and tumor chemotherapy. This paper reviewed recent progress of lipid-based doxorubicin (molecular) prodrugs and their nanodelivery systems, including lipid-doxorubicin prodrugs, stimuli-responsive lipid-doxorubicin prodrugs, and lipid-doxorubicin prodrug-based drug co-delivery nanosystems. Additionally, possible future research outlooks in this field were also discussed. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Olim, F., Neves, A. R., Wang, Z., Sun, J., Tomás, H., & Sheng, R. (2020). Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems. Medicine Research, 4(1-2), 200013. DOI: 10.21127/yaoyimr20200013 | pt_PT |
dc.identifier.doi | 10.21127/yaoyimr20200013 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.13/3820 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Medicine Research | pt_PT |
dc.relation | Madeira Chemistry Research Centre | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Lipid | pt_PT |
dc.subject | Doxorubicin | pt_PT |
dc.subject | Prodrugs | pt_PT |
dc.subject | Stimuli-responsive | pt_PT |
dc.subject | Drug co-delivery | pt_PT |
dc.subject | Nanosystems | pt_PT |
dc.subject | . | pt_PT |
dc.subject | Faculdade de Ciências Exatas e da Engenharia | pt_PT |
dc.subject | Centro de Química da Madeira | |
dc.title | Prodrug Systems (I): Lipid-based Doxorubicin Prodrugs and their nanodelivery systems | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Madeira Chemistry Research Centre | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FQUI%2F00674%2F2019/PT | |
oaire.citation.endPage | 200013 | pt_PT |
oaire.citation.issue | 1-2 | pt_PT |
oaire.citation.startPage | 200013 | pt_PT |
oaire.citation.title | Medicine Research | pt_PT |
oaire.citation.volume | 4 | pt_PT |
oaire.fundingStream | 6817 - DCRRNI ID | |
person.familyName | Olim | |
person.familyName | Neves | |
person.familyName | Tomás | |
person.familyName | Sheng | |
person.givenName | Filipe | |
person.givenName | Ana Rute | |
person.givenName | Helena | |
person.givenName | Ruilong | |
person.identifier | 556975 | |
person.identifier | https://scholar.google.ca/citations?user=YCheaFsAAAAJ&hl=en | |
person.identifier.ciencia-id | 911A-2894-E357 | |
person.identifier.ciencia-id | A51A-E760-E8B8 | |
person.identifier.ciencia-id | 4D14-D31E-A8BE | |
person.identifier.ciencia-id | C019-C809-403B | |
person.identifier.orcid | 0000-0001-8878-2067 | |
person.identifier.orcid | 0000-0003-4262-5837 | |
person.identifier.orcid | 0000-0002-7856-2041 | |
person.identifier.orcid | 0000-0002-3303-3832 | |
person.identifier.rid | O-6395-2018 | |
person.identifier.rid | H-3743-2013 | |
person.identifier.rid | E-5991-2010 | |
person.identifier.scopus-author-id | 56731303900 | |
person.identifier.scopus-author-id | 6508104177 | |
person.identifier.scopus-author-id | 7005472737 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 7b5e3c58-8660-433f-913b-a6586d86d6b3 | |
relation.isAuthorOfPublication | 095a50e4-1c1f-4589-ad19-f2564ec76a13 | |
relation.isAuthorOfPublication | 3a747114-6ab9-454b-985b-00cbf792e273 | |
relation.isAuthorOfPublication | 447440d5-343e-4804-a4fb-98584bb0749c | |
relation.isAuthorOfPublication.latestForDiscovery | 3a747114-6ab9-454b-985b-00cbf792e273 | |
relation.isProjectOfPublication | 0e558baa-fee7-4f1c-b713-f79ed1581567 | |
relation.isProjectOfPublication.latestForDiscovery | 0e558baa-fee7-4f1c-b713-f79ed1581567 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Prodrug Systems (I) Lipid-Based Doxorubicin Prodrugs and Their Nanodelivery Systems.pdf
- Size:
- 517.97 KB
- Format:
- Adobe Portable Document Format